Tenon Medical, Inc. (TNON) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Tenon Medical, Inc.'s filing signal continuing negative.

Tenon Medical, Inc. is a medical device company focused on transforming care for patients with sacro-pelvic disorders, specifically targeting the sacroiliac (SI) joint. The company offers two primary systems for SI joint fusion: The CatamaranTM SI Joint Fusion System and The SImmetry SI Joint Fusion System, acquired in August 2025. Both systems are designed for minimally invasive procedures, aiming to provide immediate fixation and promote biological fusion. The company is currently focused on the U.S. market, addressing primary SI joint procedures, revision procedures, and SI joint fusion as an adjunct to spine fusion. Tenon Medical aims to capture a larger share of the expanding SI joint fusion market by offering differentiated technologies backed by clinical evidence.

Revenue is derived from the sale of The Catamaran System and The SImmetry System to clinicians and hospitals. Fluctuations in revenue are influenced by the volume of surgical procedures, pricing, discounts, rebates, and the number of implants used per patient.